The complex aetiology of schizophrenia is postulated to share factors with other psychiatric 27 disorders. Recently, this has been supported by genome-wide association studies, with 28 several psychiatric phenotypes displaying high genomic correlation with schizophrenia. We 29 sought to investigate pleiotropy amongst the common variant genomics of schizophrenia and 30 seven other psychiatric disorders using a multimarker test of association. Gene-based analysis 31 of common variation revealed over 50 schizophrenia-associated genes shared with other 32 psychiatric phenotypes; including bipolar disorder, major depressive disorder, ADHD, and 33 autism spectrum disorder. In addition, we uncovered 78 genes significantly enriched with 34 common variant associations for schizophrenia that were not linked to any of these seven 35 disorders (P > 0.05). Transcriptomic imputation was then leveraged to investigate the 36 functional significance of variation mapped to these genes, prioritising several interesting 37 functional candidates. Pairwise meta-analysis of schizophrenia and each psychiatric 38 phenotype further revealed 330 significantly associated genes (PMeta < 2.7 x 10 -6 ) that were 39 only nominally associated with each disorder individually (P < 0.05). Multivariable gene-set 40 association suggested that common variation enrichment within biologically constrained 41 genes observed for schizophrenia also occurs across several psychiatric phenotypes. These 42 analyses consolidate the overlap between the genomic architecture of schizophrenia and other 43 psychiatric disorders and uncovered several pleiotropic genes which warrant further 44 investigation. 45
INTRODUCTION 59
Schizophrenia is a psychiatric disorder which is proposed to arise from a complex interplay 60 between heritable and environmental factors. As a polygenic disorder, the genomic 61 architecture of schizophrenia encompasses variation throughout the genome with population 62 frequencies ranging from common to ultra-rare (1-4). Genome-wide association studies 63 (GWAS) of schizophrenia have been able to recapitulate a notable proportion of the 64 heritability estimated from twin-studies, with SNP based heritability in the most recent 65 GWAS calculated to be approximately 23% on the liability scale, assuming a population 66 prevalence of 0.7% (1). This polygenic signal is distributed amongst many genes and 67 biological systems genome-wide, and thus, further research is required to fully appreciate the 68 underlying biology captured by GWAS and its relevance to the pathophysiology of 69 schizophrenia. 70
71
The diagnostic boundaries between schizophrenia and other psychiatric disorders remain 72 difficult to define. Psychiatric co-morbidities are common in patients with schizophrenia (5), 73 whilst the defined clinical presentation of the disorder itself resembles that of other 74 diagnoses. For instance, major depressive disorder (MDD) diagnosis is prevalent amongst 75 4 individuals with schizophrenia (6). However, negative symptoms inherent to schizophrenia, 76 which include avolition and asociality, are also closely linked to MDD despite their 77 classification as distinct clinical entities (7) . Collectively, this supports the existence of 78 shared aetiological factors between schizophrenia and the spectrum of psychiatric illness. 79 80 Genomic evidence reinforces this trans-diagnostic paradigm, facilitated by the GWAS now 81 available for a number of psychiatric disorders in addition to schizophrenia (8) (9) (10) (11) (12) (13) (14) . Linkage 82 disequilibrium (LD) score regression has demonstrated that schizophrenia displays positive 83 genomic correlation with several psychiatric phenotypes (15), with the most statistically 84 significant relationship observed with bipolar disorder (BIP). The biological mechanisms 85 encapsulated by these cross-disorder correlations remain largely uncharacterised. Genes and 86 systems associated with schizophrenia which exhibit pleiotropy within psychiatry, that is, a 87 significant relationship with another disorder, may be particularly biologically salient. 88
Further, elucidation of genetic factors specific to schizophrenia may aid in identifying the 89 underlying origin of clinical features which are more distinct to the disorder. Previous cross-90 disorder association analyses have largely focused on individual SNPs and consider a set of 91 psychiatric phenotypes simultaneously (16). In this study, we implemented a multimarker test 92 of association from a schizophrenia focus in relation to seven other psychiatric disorders -93 bipolar disorder (BIP), attention deficit/hyperactivity disorder (ADHD), autism spectrum 94 disorder (ASD), major depressive disorder (MDD), obsessive compulsive disorder (OCD), 95
Tourette's syndrome (TS), and eating disorder (ED). We sought to identify pleiotropic genes 96 and gene-sets which were associated with schizophrenia and at least one other phenotype. We 97 uncovered several interesting schizophrenia associated genes and gene-sets which are shared, 98 along with a subset of genes specifically linked to schizophrenia. 99 100 6 significant MDD genes), and ASD (NShared = 3, 18% of all significant ASD genes). One gene, 126
Sortilin related VPS10 domain containing receptor 3 (SORCS3), was associated with 127 schizophrenia and two of the additional disorders -ADHD and MDD (PSZ = 2.91 x 10 -8 , 128 PADHD = 1.51 x 10 -9 , and PMDD = 5.66 x 10 -8 ). 129 130 A transcriptome wide association study (TWAS) was performed for each of the disorders 131 which displayed at least one shared genic association with schizophrenia (Supplementary 132 Table 3 , 4). TWAS leverages imputed models of genetically regulated expression to identify 133 genes for which expression is genetically correlated with the trait of interest (17). We 134 implemented this approach to interpret the direction of effect of these pleiotropic genes in 135 relation to their expression. Specifically, we aimed to identify genes whose predicted 136 expression is associated with schizophrenia and at least one other psychiatric phenotype. 137
Weights were derived from the dorsolateral prefrontal cortex (DLPFC) and blood as 138 Results presented as a circular Manhattan plot for the -log10 P-value of association for each 170 gene per disorder. Significant schizophrenia genes by MAGMA which survive correction in 171 each disorder are highlighted red (P < 2.7 x 10 -6 ). Each shell of the plot represents a different 172 disorder, radiating outwards in the following order: OCD, TS, ED, ASD, MDD, ADHD, and 173
BIP. 174
8 Firstly, we considered models for significant cis-heritable genes in the DLPFC; 24 of the 67 176 candidate pleiotropic genes had available models in this tissue. The imputed expression of 177 three genes was associated with both schizophrenia and BIP (P < 9.2 x 10 -6 , corrected for the 178 5420 models tested). In two of these instances, overexpression was associated with both 179 ]. An additional gene, GLT8D1, proximally located to NEK4, also 183 survived correction the schizophrenia and BIP analyses. Conditional analysis was performed 184 to reveal whether these were conditionally independent. NEK4 was conditionally significant 185 in both disorders below the Bonferroni threshold, whilst in this construct GLT8D1 was only 186 marginally significant in schizophrenia (PConditional = 0.034) and not significant in BIP 187 (PConditional = 0.69). In addition, conditional analyses for schizophrenia of the HAPLN4 locus 188 suggested that this association was primarily explained by another gene, GATAD2A. Imputed expression models derived from blood data were applied as above, with 22 201 significant models available. Upregulation of Neuromedin B (NMB), for which expression 202
was not significantly cis-heritable in the brain, was associated with schizophrenia and BIP 203 risk. GLN3 (G protein nuclear 3) was similarly significant for schizophrenia and BIP, 204 however, due to its proximity to NEK4 this may arise from the same underlying genomic 205 signal. In blood, NEK4 does not display adequate cis-heritability for imputation, and thus, 206 conditional analyses cannot be directly performed. A pleiotropic effect for overexpression of 207
Zinc Finger DHHC-Type Containing 5 (ZDHHC5) on schizophrenia and MDD was also 208 observed using blood SNP weights -schizophrenia: ZTWAS = 5.96, P = 2.49 x 10 -9 , MDD: 209 ZTWAS = 4.54, P = 5.62 x 10 -6 . 210 211
Common variant derived genic-association specific to schizophrenia in psychiatry 212
We then sought to identify genes which were only associated with schizophrenia 213
( Supplementary Table 5 ). Firstly, the majority of genes associated with schizophrenia (N = 214 390, 86% of all genes associated with schizophrenia) did not survive Bonferroni correction 215 for any of the seven other disorders. However, as many of these genes trended towards 216 corrected significance in one or more of the phenotypes, we wanted to identify the subset of 217 genes which were not nominally significant for any other psychiatric GWAS examined in this 218 study (P > 0.05, N = 78, 17% of all genes associated with schizophrenia). The gene encoding 219 Serologically Defined Colon Cancer Antigen 8 (SDCCAG8, PSZ = 1.68 x 10 -12 ) was the most 220 significantly associated gene which did not display nominal association with any of the other 221 psychiatric traits. The top ten of these genes are presented in Table 1 . We investigated 222 biological systems for which this subset was overrepresented relative to the other 223 schizophrenia associated genes. No pathways survived multiple testing correction, however, 224 three trended towards corrected significance: Reactome: Extracellular matrix organisation 10 (P = 2.31 x 10 -3 , q = 0.0832), GO: Cellular response to stimulus (P = 6.82 x 10 -3 , q = 226 0.305), and GO: Leukocyte proliferation (P = 8.76 x 10 -3 , q = 0.305). 227 228 TWAS was also performed for this subset of genes using both the brain and blood derived 233 tissue panels. Of the genes tested, 26 and 18 models had sufficient overlapping SNP weights 234 for the analysis considering brain and blood respectively ( Supplementary Table 6 ). Nine 235 genes survived correction across both tissues. The most significant association with 236 schizophrenia in the DLPFC construct was for this subset of genes was increased predicted 237 expression of SDCCAG8 -ZTWAS = 6.16, P = 7.21 x 10 -10 . Several of these genes remained 238 significant after the application of both Bonferroni correction and conditional analysis for the 239 DLPFC models -CLNC3 (ZTWAS = 5.36, P = 8.36 x 10 -8 ), SLC45A1 (ZTWAS = -5.2, P = 1.97 240
x 10 -7 ), KCNN3 (ZTWAS = -5.14, P = 2.63 x 10 -7 ), GIGYF1 (ZTWAS = 4.59, P = 4.32 x 10 -6 ), 241 and FAM114A2 (ZTWAS = -4.51, P = 6.54 x 10 -6 ). However, after conditional analysis 242 considering proximally located associations, SDCCAG8 was only marginally significant (P = 243 0.016), with another gene at this locus (CEP170) explaining the majority of the association. 244
In addition, the two genes which survived correction for blood were also only marginally 245 to have high neurological expression we repeated these analyses adjusted for gene-wise 263 expression in the brain (1, 20). After covariation for the expression of each gene in the 264 cortex, this signal remained at least nominally significant in all disorders except ED and OCD 265
( Supplementary Table 7 ). BIP and schizophrenia demonstrated a notably strong signal for 266 enrichment within the FMRP targets (Schizophrenia: = 0.245, SE = 0.0352, P = 1.15 x 10 -9 , 267 BIP: = 0.157, SE = 0.0493, P = 3.93 x 10 -6 ). The remaining phenotypes all demonstrated 268 nominal association with the exception of ADHD, with only a minor effect of adjustment for 269 gene-wise brain expression analogous to the models for the biologically constrained gene-set 270
( Supplementary Table 8 ). 271 272 Gene-set association analysis was then undertaken using 7296 hallmark, canonical, and gene 273 ontology (GO) gene-sets from MSigDB. Fifteen of these gene-sets were associated with 274 schizophrenia after Bonferroni correction (P < 6.8 x 10 -6 , Supplementary Table 9 ). The three 275 most significant gene-sets were as follows: Neuron projection ( = 0.223, SE = 0.0383, P = 276 3.23 x 10 -9 ), Somatodendritic compartment ( = 0.254, SE = 0.0452, P = 9.58 x 10 -9 ), and 277
High voltage gated calcium channel activity ( = 2.1, SE = 0.376, P = 1.09 x 10 -8 ). When 278 gene-set association was performed for the remaining seven phenotypes, none of the fifteen 279 schizophrenia associated gene-sets survived Bonferroni correction for any disorder 280 ( Supplementary Table 10 As there is evidence of wide spread pleiotropy amongst genic associations with schizophrenia 326 in relation to other psychiatric phenotypes, we aimed to further characterise shared common 327 variant genomics using meta-analysis weighted by the sample size of individual GWAS. 328
Schizophrenia was meta-analysed at gene-level in a pairwise fashion with the remaining 329 psychiatric GWAS in order to identify genes which, i) survived multiple testing correction 330 (PMeta < 2.7 x 10 -6 ) in each meta-analysis but did not survive correction in the respective 331 individual GWAS (P < 0.05, P > 2.7 x 10 -6 ). All seven meta-analyses of schizophrenia and 332 one other psychiatric disorder revealed at least one sub-threshold pleiotropic gene which 333 satisfied the above criteria ( Supplementary Table 11, Supplementary Figure 1) . The 334 schizophrenia/BIP model yielded the largest number of novel genic associations (NNovel = 335 175, Lowest P: TSNAXIP1, P = 2.83 x 10 -10 - Fig. 3a) . Thereafter, the schizophrenia/ADHD 336 (NNovel = 65, Lowest P: ARTN, P = 1.6 x 10 -9 - Fig. 3b ) and schizophrenia/ASD (NNovel = 58, 337
Lowest P: CXXC4, P = 2.04 x 10 -8 - Fig. 3c ) meta-analyses had the most novel genic 338 associations. Several previously postulated psychiatric risk genes from candidate studies were 339 revealed in these constructs, including Neural cell adhesion molecule 1 (NCAM1) which was 340 significant in the schizophrenia and BIP model (22, 23) Manhattan plot for each meta-analysis which displays the -log10 transformed P value for 390 association for genes which were tagged by at least one SNP in the respective GWAS. The 391 red line represents the Bonferroni threshold for multiple testing correction (P < 2.7 × 10 -6 ). 392
Genes highlighted on each plot were not Bonferroni significant in the individual GWAS but 393 obtained corrected significance in the meta-analysis. We investigated the common variant genomic architecture of schizophrenia relative to a 401 range of psychiatric disorders. Previous work has suggested that there is a significant 402 relationship between the genetics of schizophrenia and the spectrum of psychiatric 403 phenotypes (27, 28), which is not unexpected given the analogous aspects of their respective 404 clinical presentations. Gene-based analysis consolidated this aetiological overlap as 405 schizophrenia shared several significant genic associations with other psychiatric disorders. 406 MDD and BIP demonstrated the largest number of shared schizophrenia genes relative to the 407 total number of genes significant for each disorder, consistent with the strong genetic 408 correlation between schizophrenia and these phenotypes. Interestingly, the most strongly 409 associated schizophrenia gene in this study, CACNA1C, was also strongly enriched with 410 common variant associations for BIP. The Cav1.2 L-type voltage-gated calcium channel a1c 411 subunit is encoded by CACNA1C, which is postulated to play an important role in synaptic 412 plasticity (29-31). 413
The majority of schizophrenia associated genes were not significant for any other disorder 414 after the application of multiple testing correction. However, a large proportion of these 415 genes displayed some degree of nominal significance (P < 0.05) -thus, we identified a subset 416 of schizophrenia genes which displayed no evidence of association with any other psychiatric 417 disorder (P > 0.05). This strict threshold was chosen as the sample sizes differ amongst the 418 respective GWAS and future increases in sample sizes may yet reveal nominal P values 419 which survive multiple testing correction. The biological saliency of variation mapped to a 420 subset of these genes was supported by TWAS. For instance, decreased predicted expression 421 of the potassium channel KCNN3 was associated with schizophrenia. Dopamine homeostasis 422 has been extensively linked to this protein, with blockade shown to increase spike firing of 423 dopaminergic neurons, along with potentiated dopamine release (32, 33). Downregulation of 424 KCNN3, therefore, is consistent with overarching dopamine hypotheses related to 425 schizophrenia, supporting its relevance for pathogenesis of the disorder. 426
427
The enrichment of common variant associations within genes under biological constraint was 428 shown to be relatively ubiquitous across most of the psychiatric phenotypes considered in this 429 study. These mutation intolerant regions of the genome are subject to purifying selection and, 430 thus, it may appear contradictory that risk alleles for psychiatric disorders persist in these 431 genes at common frequencies. It has been postulated that linkage between regions under 432 repeated selection results in the loss of haplotypes, in turn, attenuating the strength of 433 selection on individual sites (1, 34, 35) . This weakened selective pressure is theorised to 434 account for the increase in frequency of these risk alleles through the action of enhanced 435 genetic drift (34, 36). Therefore, this mechanism of common variant enrichment within 436 constrained regions appears to be an important aspect of the genomic architecture of several 437 psychiatric disorders which is shared with schizophrenia. OCD did not display a significant 438 association with this gene-set, as perhaps would be expected, however, the small sample size 439 of its GWAS may account for this. Deleterious rare variation within these regions has also 440 shown to be enriched for schizophrenia and ASD, consolidating the multi-faceted nature of 441 genomic risk for these disorders (3, 37) . 442
443
This study refines the nature of common variant informed genetic overlap between 444 schizophrenia and other psychiatric conditions. A number of interesting pleiotropic 445 candidates were revealed in this study which warrant further functional investigation to 446 elucidate their significance to the respective phenotypes. For instance. SORCS3, the most 447 pleiotropic schizophrenia-associated gene uncovered by these analyses due to its association 448 with two of the other disorders considered, is implicated in a number of neurologically salient 449 processes including modulation of synaptic depression and glutamate receptor functionality 450 (38, 39) . There are a number of important limitations to this study. Firstly, this work relies on 451 the diagnostic definitions encompassed within each GWAS, however, the true incidence of 452 psychiatric comorbidities amongst the respective study participants is unknown. Despite the 453 uncertainty of psychiatric nosology, schizophrenia associated genes involved with another 454 psychiatric GWAS does suggest that these shared genes may be particularly biologically 455 salient. Further, the non-pleiotropic subset of genes identified in this study may be associated 456 with other psychiatric phenotypes not considered in this study. We utilised common variant 457 data for this study. Whilst common variation is an integral component of psychiatric 458 heritability, future cross-disorder investigation of genes and systems significantly enriched 459 with rare loci will be integral to fully appreciate the spectrum of biology which constitutes 460 the shared factors which exist between schizophrenia and these disorders. Genic coordinates 461 for SNP annotation was also largely constrained to protein coding genes, however, previous 462 evidence has suggested that non-coding RNA play an important role in psychiatric disorders, 463 20 with variation mapped to the microRNA host gene MIR137HG a notable significant GWAS 464 signal for schizophrenia (40) . Future study should consider if there are shared association 465 signals mapped to these non-coding RNA, particularly as transcriptomic imputation has not 466 yet thoroughly applied to small RNA sequencing data. European GWAS data were chosen 467 for these analyses as diverse well-powered summary statistics are still not readily available 468 for many psychiatric traits. There are important ancestral differences between haplotype 469 structure, and thus, it is essential that GWAS are more widely performed for non-European 470 ancestral groups so that work of this fashion can be consolidated and leveraged in an 471 inclusive fashion. Finally, the principal multimarker test employed for gene discovery in this 472 study, MAGMA, is based on P-value combination and assigns variants to genes using their 473 genomic coordinates. This does not directly inform the effect size or functional significance 474 of variation which constitutes these gene-based P values. TWAS helps to overcome this by 475 assigning weights to SNPs based on the cis-heritability of their respective genes. However, 476 TWAS relies on genotyped expression datasets of modest sample sizes, with many genes 477 lacking a suitable imputed model of genetically regulated expression. Further study is 478 required to advance these multimarker approaches such that statistical effect size and 479 functional annotation beyond cis-regulatory annotations can be included. Enhanced models 480 which integrate this information will facilitate the biological interpretation of schizophrenia 481 associated genes shared with other disorders 482 483
MATERIALS AND METHODS 484

GWAS summary statistics 485
The largest European ancestry GWAS with full genome-wide summary statistics available 486 was obtained for schizophrenia (N = 105318, Pardiñas et al. (1)) and seven other psychiatric 487 disorders. The other disorders and their respective GWAS were as follows: bipolar disorder 488
